Drugs / CRD3874-SI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07661095 | Jun 2026 → Jun 2028 expected | acute myeloid leukemia | Memorial Sloan Kettering Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRD3874-SI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07661095 ↗ |
| Action | Activate | “CRD3874-SI is a STING (Stimulator of Interferon Genes) agonist” NCT07661095 ↗ |